Compugen reported 5.45 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.45 1.39 Mar/2026
RedHill Biopharma 0.04 0.03 Jun/2025
TherapeuticsMD 0.75 3.3 Mar/2023